| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $38.0M | +21.4% |
| Cost of Revenue | $10.8M | +197.1% |
| R&D Expense | $9.1M | -1.6% |
| SG&A Expense | $64.9M | +28.3% |
| Operating Income | -$50.6M | -4935.7% |
| Interest Expense | $9.6M | — |
| Pre-tax Income | -$23.4M | +73.6% |
| Income Tax | $4K | -20.0% |
| Net Income | -$23.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.2M | +330.0% |
| Accounts Receivable | $21.2M | +48.8% |
| Inventory | $1.4M | -46.2% |
| Current Assets | $29.6M | +5677.7% |
| Total Assets | $86.5M | -38.2% |
| Current Liabilities | $44.8M | — |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.3M | -2552.8% |
| Capital Expenditures | $7K | — |
| Investing Cash Flow | -$2.1M | +98.5% |
| Financing Cash Flow | $21.2M | -84.9% |
| Free Cash Flow | -$21.3M | -2553.7% |
| -3082.2% |
| EPS (Basic) | -$0.17 | -440.0% |
| EPS (Diluted) | -$0.17 | -440.0% |
| Total Liabilities |
| $50.3M |
| +444.2% |
| Stockholders' Equity | $36.2M | +516.7% |